Latest filing published 03 Mar 2026 for Bausch Health Companies Inc., €417k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas Appio (chief executive) discloses dealings in Bausch Health Companies Inc. to SEC (Form 4). Over a trading history stretching from 1 September 2021 to 2 March 2026, the count stands at 20 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 March 2026 with a share grant (€417k) in Bausch Health Companies Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations